Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.

Marcoval J, Notario J, Martín C, Gómez S.

Actas Dermosifiliogr. 2014 Mar;105(2):211-2. doi: 10.1016/j.ad.2013.01.008. Epub 2013 Apr 25. English, Spanish. No abstract available.

PMID:
23623282
2.

Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.

Aguayo-Leiva I, Pérez B, Salguero I, Jaén P.

Eur J Dermatol. 2009 May-Jun;19(3):291-2. doi: 10.1684/ejd.2009.0665. Epub 2009 Mar 13. No abstract available.

PMID:
19286489
3.

Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.

Yaşar B, Yaşar Ş, Güneş P.

Turk J Gastroenterol. 2015 Mar;26(2):189-90. doi: 10.5152/tjg.2015.6052. No abstract available.

4.

Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.

Ghosh S, Duseja A, Dhiman RK, Chawla YK.

Dig Dis Sci. 2012 Mar;57(3):820-1. doi: 10.1007/s10620-011-1914-5. Epub 2011 Sep 24.

PMID:
21948358
5.

Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.

Mlika RB, Kerkeni N, Marrak H, Fenniche S, Mokhtar I, Debbiche A.

Int J Dermatol. 2013 May;52(5):643-4. doi: 10.1111/j.1365-4632.2011.04921.x. Epub 2012 Oct 9. Review. No abstract available.

PMID:
23046405
6.

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.

Lin J, Lott JP, Amorosa VK, Kovarik CL.

J Am Acad Dermatol. 2009 May;60(5):882-3. doi: 10.1016/j.jaad.2008.10.006. No abstract available.

PMID:
19389538
7.

Tongue hyperpigmentation during interferon therapy.

Karabay O, Goksugur N, Ogutlu A.

J Dermatol. 2011 Mar;38(3):290-1. doi: 10.1111/j.1346-8138.2010.01022.x. Epub 2010 Oct 6. No abstract available.

PMID:
21342236
8.

Tongue hyperpigmentation during hepatitis C treatment.

Bachmeyer C, Pellen JC.

CMAJ. 2012 Sep 18;184(13):1498. doi: 10.1503/cmaj.111985. Epub 2012 Mar 26. No abstract available.

9.

What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?

Radha Krishna Y, Itha S.

Liver Int. 2010 Mar;30(3):416. doi: 10.1111/j.1478-3231.2009.02025.x. Epub 2009 Apr 28. No abstract available.

PMID:
19422481
10.

[Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].

Savoye G, Goria O, Herve S, Riachi G, Noblesse I, Bastien L, Courville P, Lerebours E.

Gastroenterol Clin Biol. 2000 Jun-Jul;24(6-7):679. French. No abstract available.

11.

Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.

Bektas M, Bektas H, Gören D, Altan M, Cetinkaya H.

Digestion. 2007;75(4):208-9. Epub 2007 Oct 10. No abstract available.

12.

Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C.

Tappero G, Ballaré M, Farina M, Negro F.

J Hepatol. 1998 Dec;29(6):1033-4. No abstract available.

PMID:
9875657
13.

Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.

Wendling J, Descamps V, Grossin M, Marcellin P, Le Bozec P, Belaich S, Crickx B.

Arch Dermatol. 2002 Apr;138(4):546-7. Review. No abstract available.

PMID:
11939833
14.

High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.

Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E.

Arch Dermatol. 1999 Aug;135(8):1000-1. No abstract available.

PMID:
10456365
15.

[Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].

Christensen UB, Krogsgaard K.

Ugeskr Laeger. 2004 Mar 8;166(11):1024-5. Danish. No abstract available.

PMID:
15049242
16.

Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.

Papastathopoulos K, Bouzas E, Naoum G, Vergados I, Tsiodras S.

J Infect. 2006 Feb;52(2):e59-61. Epub 2005 Jun 13.

PMID:
15951019
17.
18.

Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.

Savk E, Uslu G, Karaoğlu AO, Sendur N, Karaman G.

J Eur Acad Dermatol Venereol. 2005 May;19(3):396-8. No abstract available.

PMID:
15857485
19.

[Dysacusia associated with pegylated-interferon and ribavirin combination therapy during chronic hepatitis C treatment: a report of two cases].

Jia YH, Gao SJ, Nan YM.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jan;20(1):67-8. Chinese. No abstract available.

PMID:
22489302
20.

[Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].

Iwasaki Y, Ikeda F, Yamamoto K.

Nihon Rinsho. 2011 May;69 Suppl 4:215-20. Review. Japanese. No abstract available.

PMID:
22096922
Items per page

Supplemental Content

Write to the Help Desk